Find therapies in clinical trials near you – page 38

Study on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis

Study on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis

Study on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis

Study on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis

Study on the Effectiveness and Safety of Reparixin for Adults with Acute Respiratory Distress Syndrome

Study on the Effectiveness and Safety of Reparixin for Adults with Acute Respiratory Distress Syndrome

Study Comparing Savolitinib and Osimertinib with Chemotherapy for Advanced Non-Small Cell Lung Cancer in Patients with EGFR Mutation and MET Overexpression

Study on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Study on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Study on Organ Preservation for Early Stage Esophageal Cancer Using Durvalumab and Chemoradiation for Patients Eligible for Surgery

Study on Organ Preservation for Early Stage Esophageal Cancer Using Durvalumab and Chemoradiation for Patients Eligible for Surgery

Study of RMC-035 to prevent kidney injury in patients undergoing open-chest heart surgery

Study of RMC-035 to prevent kidney injury in patients undergoing open-chest heart surgery

Study of dupilumab effectiveness compared to placebo in adults with bullous pemphigoid

Study of dupilumab effectiveness compared to placebo in adults with bullous pemphigoid

Study on Frexalimab for Patients with Relapsing Multiple Sclerosis

Study on Frexalimab for Patients with Relapsing Multiple Sclerosis

Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa

Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa

Study of Nivolumab for Patients with High-Risk Stage II Melanoma After Surgery

Study of Nivolumab for Patients with High-Risk Stage II Melanoma After Surgery

Study on the Effects of Barzolvolimab for Patients with Prurigo Nodularis

Study on the Effects of Barzolvolimab for Patients with Prurigo Nodularis